Corrigendum to “Simultaneously deplete reactive oxygen species and inhibit pyroptosis by dopamine/thioketal-containing polymers delivering disulfiram in combination with Cu(II) for acute glaucoma” [Nano Today 47 (2022) 101668]

Zhou, Xuezhi; Rong, Rong; Liang, Ganghao; Li, Haibo; You, Mengling; Zhou, Zhongmin; Xiao, Haihua; Ji, Dan; Xia, Xiaobo

doi:10.1016/j.nantod.2022.101724

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, more significant therapeutic interventions are required to treat or stop the disease's progression. To date, many nanomaterials have been developed for the treatment of surface organ-associated diseases in fundamental research, such as photocleavage nanodrugs [102] and 89 WP-MEL [103] for retinoblastoma, NP1 [104] and DSF-NPs [105] for glaucoma, MNFs@V-H@DA for wound healing, [106] KPV-Lipo for vitiligo, [107] and α-melittin-np for allergic dermatitis, [108] which bring great potential for the treatment of these diseases. Similar to the nanomaterials mentioned above and others, AIEgens also have great potential in the treatment of surface organ-associated diseases.…”

Section: Aiegen-based Theranostics In Surface Organ-associated Diseasementioning

confidence: 99%

Recent advances of aggregation‐induced emission in body surface organs

Li,

Zhang,

Liao

et al. 2023

Aggregate

View full text Add to dashboard Cite

The surface organs mainly comprise the superficial layers of various parts of the mammalian body, including the skin, eyes, and ears, which provide solid protection against various threats to the entire body. Damage to surface organs could lead to many serious diseases or even death. Currently, despite significant advancements in this field, there remain numerous enigmas that necessitate expeditious resolution, particularly pertaining to diagnostic and therapeutic objectives. The advancements in nanomedicine have provided a significant impetus for the development of novel approaches in the diagnosis, bioimaging, and therapy of superficial organs. The aggregation‐induced emission (AIE) phenomenon, initially observed by Prof. Ben Zhong Tang, stands out due to its contrasting behavior to the aggregation‐caused quenching effect. This discovery has significantly revolutionized the field of nanomedicine for surface organs owing to its remarkable advantages. In this review of literature, we aim to provide a comprehensive summary of recent advances of AIE lumenogen (AIEgen)‐based nanoplatforms in the fields of detection, diagnosis, imaging, and therapeutics of surface organ‐related diseases and discuss their prospects in the domain. It is hoped that this review will help attract researchers’ attention toward the utilization of this field for the exploration of a wider range of biomedical and clinical applications.

show abstract

Section: Aiegen-based Theranostics In Surface Organ-associated Diseasementioning

confidence: 99%